Ocular Therapeutix Inc (NASDAQ:OCUL)

25.24
Delayed Data
As of May 21
 -0.28 / -1.10%
Today’s Change
11.90
Today|||52-Week Range
44.19
+7.31%
Year-to-Date

Today’s Trading

Previous close25.52
Today’s open25.26
Day’s range-- - --
Volume149,527
Average volume (3 months)288,586
Market cap$541.1M
Dividend yield--
Data as of 05/21/2015

Growth & Valuation

Earnings growth (last year)-668.57%
Earnings growth (this year)+46.96%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales324.55
Price/Book9.17

Competitors

 Today’s
change
Today’s
% change
XENTIntersect ENT Inc-1.31-5.34%
RMTIRockwell Medical Inc-0.02-0.19%
ANGOAngioDynamics Inc-0.22-1.36%
ANIKAnika Therapeutics I...-0.05-0.15%
Data as of 05/21/2015

Financials

Last reporting dateMay 15, 2015
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$772.0K
Annual profit (last year)-$28.6M
Net profit margin-3,710.88%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Amarpreet S. Sawhney
Chief Operating Officer
James Fortune
Corporate headquarters
Bedford, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers